Rice Hall James & Associates, LLC Y M Abs Therapeutics, Inc. Transaction History

Rice Hall James & Associates, LLC

  • $1.66 Billion
  • Q4 2024

A detailed history of Rice Hall James & Associates, LLC transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 108,549 shares of YMAB stock, worth $648,037. This represents 0.05% of its overall portfolio holdings.

Number of Shares
108,549
Previous 108,684 0.12%
Holding current value
$648,037
Previous $1.43 Million 40.5%
% of portfolio
0.05%
Previous 0.08%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025
SELL
$7.76 - $15.69 $1,047 - $2,118
-135 Reduced 0.12%
108,549 $849,000
Q3 2024

Oct 28, 2024
BUY
$9.95 - $15.39 $188,542 - $291,625
18,949 Added 21.12%
108,684 $1.43 Million
Q2 2024

Aug 07, 2024
BUY
$11.6 - $17.25 $41,632 - $61,910
3,589 Added 4.17%
89,735 $1.08 Million
Q1 2024

Apr 23, 2024
BUY
$6.57 - $18.69 $4,158 - $11,830
633 Added 0.74%
86,146 $1.4 Million
Q4 2023

Feb 08, 2024
SELL
$4.88 - $7.42 $27,991 - $42,561
-5,736 Reduced 6.29%
85,513 $583,000
Q3 2023

Nov 02, 2023
SELL
$4.86 - $7.23 $8,616 - $12,818
-1,773 Reduced 1.91%
91,249 $497,000
Q2 2023

Jul 24, 2023
BUY
$5.68 - $10.34 $20,118 - $36,624
3,542 Added 3.96%
93,022 $631,000
Q1 2023

May 11, 2023
BUY
$2.83 - $5.11 $6,763 - $12,212
2,390 Added 2.74%
89,480 $448,000
Q4 2022

Jan 27, 2023
SELL
$3.0 - $15.17 $10,725 - $54,232
-3,575 Reduced 3.94%
87,090 $0
Q3 2022

Nov 01, 2022
SELL
$13.96 - $19.67 $17,212 - $24,253
-1,233 Reduced 1.34%
90,665 $1.31 Million
Q2 2022

Aug 08, 2022
BUY
$8.22 - $15.13 $12,519 - $23,042
1,523 Added 1.69%
91,898 $1.39 Million
Q1 2022

May 05, 2022
BUY
$6.55 - $17.42 $39,169 - $104,171
5,980 Added 7.09%
90,375 $1.07 Million
Q4 2021

Feb 14, 2022
SELL
$15.51 - $29.31 $231,036 - $436,601
-14,896 Reduced 15.0%
84,395 $1.37 Million
Q3 2021

Nov 09, 2021
BUY
$27.47 - $37.31 $69,141 - $93,909
2,517 Added 2.6%
99,291 $2.83 Million
Q2 2021

Jul 29, 2021
SELL
$25.45 - $37.64 $108,264 - $160,120
-4,254 Reduced 4.21%
96,774 $3.27 Million
Q1 2021

May 14, 2021
BUY
$29.16 - $51.96 $991 - $1,766
34 Added 0.03%
101,028 $3.06 Million
Q4 2020

Feb 16, 2021
BUY
$37.86 - $54.26 $243,326 - $348,729
6,427 Added 6.8%
100,994 $5 Million
Q3 2020

Nov 16, 2020
BUY
$35.13 - $43.62 $1.06 Million - $1.32 Million
30,241 Added 47.01%
94,567 $3.63 Million
Q2 2020

Aug 14, 2020
BUY
$23.66 - $49.53 $16,514 - $34,571
698 Added 1.1%
64,326 $2.78 Million
Q1 2020

May 15, 2020
BUY
$14.39 - $35.8 $346,252 - $861,419
24,062 Added 60.81%
63,628 $1.66 Million
Q4 2019

Jan 29, 2020
BUY
$23.81 - $33.78 $942,066 - $1.34 Million
39,566 New
39,566 $1.24 Million

Others Institutions Holding YMAB

# of Institutions
106
Shares Held
24.5M
Call Options Held
40.3K
Put Options Held
400
View Full List

About Y-mAbs Therapeutics, Inc.

YMAB Quotes by TradingView
  • Ticker YMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,719,500
  • Market Cap $261M
  • Description
  • Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...
More about YMAB
Track This Portfolio

Track Rice Hall James & Associates, LLC Portfolio

Follow Rice Hall James & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email